menu search

Verve therapeutics: early-stage biotech with a large market

Verve Therapeutics is a biotechnology company with a vision to provide cutting-edge solutions to cardio...

April 16, 2022, 12:31 am

Merit medical systems to announce first quarter results on april 27, 2022

SOUTH JORDAN, Utah, April 13, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary ...

April 13, 2022, 1:29 pm

Accenture (acn) joins health data collaborative, ai4betterhearts

Accenture's (ACN) goal behind joining the collaborative is to support and advance cardiovascular diseas...

April 4, 2022, 12:03 pm

Philips' (phg) innovative product suite to cheer investors

Philips (PHG) launches two major cardiological innovations at ACC 2022, adding strength and depth to it...

April 1, 2022, 3:38 pm

cardiol therapeutics looks ahead to busy 2022 as it advances new treatment options for cardiovascular disease

cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc CEO David Elsley told investors that the clinical-stag...

March 24, 2022, 10:04 am

Cincor pharma to report fourth quarter and full year 2021 financial results and host conference call on march 22, 2022

BOSTON, March 15, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC), a clinical-stage biopharmaceutical company focused on developing its le...

March 15, 2022, 9:41 am

cardiol therapeutics says jennifer m. chao has been appointed as director of the company

cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc has announced that Jennifer M. Chao has been appointed...

March 15, 2022, 8:16 am

cardiovascular systems' (csii) low procedure volume dents sales

cardiovascular Systems (CSII) notes that recovery from the Delta variant has been suppressed by the eme...

March 14, 2022, 1:32 pm

Windtree to present at oppenheimer's 32nd annual healthcare conference

WARRINGTON, Pa., March 10, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused o...

March 10, 2022, 8:00 am

cardiol therapeutics receives clearance to expand eligible patient group for its lancer study

cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced it has received clearance from the US Food a...

March 1, 2022, 11:34 am

cardiol therapeutics receives clearance to expand eligible patient group for its lancer study

cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced it has received clearance from the US Food a...

March 1, 2022, 11:34 am

cardiol therapeutics receives clearance to expand eligible patient group for its lancer study

cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced it has received clearance from the US Food a...

March 1, 2022, 11:34 am

Astrazeneca and neurimmune land us$760mln deal for heart disease drug

AstraZeneca PLC (LSE:AZN) shares jumped this morning after it announced an exclusive US$760mln deal with Neurimmune to develop a drug to combat heart ...

March 1, 2022, 5:20 am

Astrazeneca and neurimmune land us$760mln deal for heart disease drug

AstraZeneca PLC (LSE:AZN) shares jumped this morning after it announced an exclusive US$760mln deal with Neurimmune to develop a drug to combat heart ...

March 1, 2022, 5:20 am

Astrazeneca and neurimmune land us$760mln deal for heart disease drug

AstraZeneca PLC (LSE:AZN) shares jumped this morning after it announced an exclusive US$760mln deal with Neurimmune to develop a drug to combat heart ...

March 1, 2022, 5:20 am

Merit medical's (mmsi) q4 earnings, revenues top estimates

Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in both its segments, and from majority of the product categories within its...

February 28, 2022, 12:16 pm

Merit medical's (mmsi) q4 earnings, revenues top estimates

Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in both its segments, and from majority of the product categories within its...

February 28, 2022, 12:16 pm

Merit medical's (mmsi) q4 earnings, revenues top estimates

Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in both its segments, and from majority of the product categories within its...

February 28, 2022, 12:16 pm

Verve therapeutics to present at the cowen 42nd annual healthcare conference

CAMBRIDGE, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, a biotechnology company pioneering a new approach to the care of ...

February 23, 2022, 6:30 am

Verve therapeutics to present at the cowen 42nd annual healthcare conference

CAMBRIDGE, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, a biotechnology company pioneering a new approach to the care of ...

February 23, 2022, 6:30 am


Search within

Pages Search Results: